First Hawaiian Bank Raises Holdings in Avantor, Inc. (NYSE:AVTR)

First Hawaiian Bank raised its holdings in Avantor, Inc. (NYSE:AVTR) by 28.7% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 109,100 shares of the company’s stock after purchasing an additional 24,342 shares during the quarter. First Hawaiian Bank’s holdings in Avantor were worth $2,299,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. UMB Bank n.a. purchased a new stake in Avantor in the third quarter valued at approximately $49,000. Nisa Investment Advisors LLC raised its holdings in shares of Avantor by 69.6% in the 3rd quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock valued at $53,000 after buying an additional 835 shares during the period. GAMMA Investing LLC lifted its stake in Avantor by 89.9% during the 3rd quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock worth $70,000 after acquiring an additional 1,285 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt boosted its holdings in Avantor by 278.0% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 5,031 shares of the company’s stock valued at $130,000 after acquiring an additional 3,700 shares during the period. Finally, Quarry LP grew its position in Avantor by 4,489.1% in the 2nd quarter. Quarry LP now owns 6,333 shares of the company’s stock valued at $134,000 after acquiring an additional 6,195 shares in the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

Avantor Price Performance

AVTR stock opened at $22.13 on Thursday. The business has a 50 day moving average price of $21.54 and a 200 day moving average price of $23.35. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84. The stock has a market cap of $15.06 billion, a price-to-earnings ratio of 48.11, a PEG ratio of 2.75 and a beta of 1.28. Avantor, Inc. has a fifty-two week low of $19.59 and a fifty-two week high of $28.00.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on AVTR shares. Royal Bank of Canada reissued an “outperform” rating and set a $34.00 price target on shares of Avantor in a research report on Thursday, September 26th. Robert W. Baird dropped their price target on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research note on Monday, October 28th. Wells Fargo & Company reduced their price objective on Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a research note on Monday, October 28th. UBS Group lowered their target price on Avantor from $30.00 to $29.00 and set a “buy” rating for the company in a research note on Tuesday, October 8th. Finally, Barclays reduced their price target on Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research report on Friday, October 25th. Two investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Avantor has an average rating of “Moderate Buy” and an average target price of $27.69.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.